Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | Megestrol acetate + Sodium cridanimod |
Synonyms | |
Therapy Description | |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
Megestrol acetate | Megace | MGA|Linmegestrol|Magestin|Megestat|Megeron | Megace (megestrol acetate) is a progestin that activates progesterone receptor signaling and blocks luteinizing hormone signaling, which may lead to potential anti-estrogen and antitumor activities (PMID: 2471590). | |
Sodium cridanimod | Virexxa|XBIO-101|Camedon|Neovir | Sodium cridanimod (Virexxa) is the sodium salt of the small molecule cridanimod, which may increase progesterone receptor expression, potentially resulting in increased sensitivity to progestin therapy (NCI Drug Dictionary). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT03077698 | Phase II | Megestrol acetate + Sodium cridanimod | An Endometrial Cancer Study for Women With Recurrent or Persistent Endometrial Cancer | Terminated | USA | 0 |